@Article{Li2015,
journal="Gastroenterology Review/Przegląd Gastroenterologiczny",
issn="1895-5770",
volume="10",
number="2",
year="2015",
title="Haemophagocytic lymphohistiocytosis in inflammatory bowel disease with virus infection",
abstract="Patients with inflammatory bowel disease (IBD) are at risk of developing haemophagocytic lymphohistiocytosis (HLH) because of chronic systemic inflammation as well as exposure to immunosuppressive medications. The two main causes of HLH in IBD patients are infection with cytomegalovirus and Epstein-Barr virus. Patients with Crohn’s disease are more susceptible to HLH than those with ulcerative colitis. The majority of cases are seen in people receiving an immunosuppressive regimen that included thiopurines.",
author="Li, Yuan
and Xia, Xuefeng
and Zhang, Jing
and Song, Zhiqiang
and Zhou, Liya
and Zhang, Yaopeng
and Huang, Yonghui
and Shi, Yanyan
and Quigley, Eamonn M.M.
and Ding, Shigang",
pages="78--82",
doi="10.5114/pg.2015.48995",
url="http://dx.doi.org/10.5114/pg.2015.48995"
}